- Business
- Swire Pacific Limited is a Hong Kong-based international conglomerate that operates as the publicly quoted arm of the Swire Group, with core interests in property, beverages, aviation, trading and industrial, and emerging healthcare businesses centered on Greater China and Southeast Asia. Swire Pacific develops, owns, and manages mixed-use commercial properties including Pacific Place and Taikoo Place in Hong Kong, Taikoo Li retail destinations and office towers in mainland China such as HKRI Taikoo Hui in Shanghai and Taikoo Place Beijing, as well as residential trading projects and hotels; through its Beverages division under Swire Coca-Cola, it manufactures, markets, and distributes Coca-Cola products including sparkling beverages, juices, teas, energy drinks, and water across mainland China, Hong Kong, Taiwan, Vietnam, Cambodia, Thailand, and Laos; in Aviation, it holds a significant stake in Cathay Pacific Airways providing passenger and cargo services, alongside HAECO group operations offering flight catering, ramp handling, cargo terminals, airframe and component maintenance, and engine overhaul services; Trading and Industrial encompasses automotive distribution via Zung Fu, marine services, and industrial activities; Healthcare involves investments in hospital networks such as DeltaHealth for cardiovascular care, Columbia China, New Frontier GBA Healthcare, and Indonesia Healthcare Corporation. The company maintains headquarters in Hong Kong, traces its origins to 1866, and generates the majority of revenue outside Hong Kong across Asia Pacific markets. Recent developments include the completion of Brickell City Centre retail and parking sales in Miami for up to US$548.7 million and adjacent land disposals totaling over US$250 million in 2025 as part of capital recycling under a HK$100 billion investment plan with 67% committed; full ownership acquisition of Mandarin Oriental Miami via a 25% stake purchase for US$37 million ahead of redevelopment; inauguration of a US$136 million LEED Gold-certified flagship plant in Vietnam in July 2025 alongside new facilities in mainland China; increased stakes in ThaiNamthip beverages, Taikoo Place Beijing, Citygate, and Zung Fu; opening of Bali International Hospital in April 2025; Cathay Pacific's expansion to 100 passenger destinations and orders for 14 additional aircraft; HAECO's relocation to Xiamen airport; and a share buy-back program concluding in May 2025 with HK$5.9 billion repurchased.